| Role |
Name |
Disclosure |
Details |
| Author | Hakan Leblebicioglu, MD, Chairman, Professor, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis University Medical School, Turkey | Nothing to disclose | Details | | Coauthor | Itzhak Brook, MD, MSc, Professor, Department of Pediatrics, Georgetown University School of Medicine | Nothing to disclose | Details | | Medical Editor | David Jaimovich, MD, Chief Medical Officer, Joint Commission International and Joint Commission Resources | Nothing to disclose | Details | | Pharmacy Editor | Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine | Pfizer Inc Avanir Pharma | Details | | Managing Editor | Leslie L Barton, MD, Professor, Program Director, Department of Pediatrics, University of Arizona School of Medicine | Nothing to disclose | Details | | CME Editor | Robert W Tolan Jr, MD, Chief, Division of Allergy, Immunology and Infectious Diseases, The Children's Hospital at Saint Peter's University Hospital; Clinical Associate Professor of Pediatrics, Drexel University College of Medicine | GlaxoSmithKline MedImmune MedImmune Merck Novartis sanofi pasteur sanofi pasteur sanofi pasteur Tap | Details | | Chief Editor | Russell W Steele, MD, Head, Division of Pediatric Infectious Diseases, Ochsner Children's Health Center; Clinical Professor, Department of Pediatrics, Tulane University School of Medicine | None | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| David Jaimovich, Medical Editor |
The contributor discloses no conflict of interest. |
|